MPO and acute respiratory distress syndrome: In acute respiratory distress syndrome (ARDS), nimbolide reported to significantly inhibit nitrosative-oxidative stress, managed inflammatory cytokines, and iNOS, myeloperoxidase, and nitro tyrosine levels (34).